跳至主要内容
临床试验/DRKS00040872
DRKS00040872进行中(未招募)不适用

Does Augmented Reality Improve Disease Understanding and Outcomes in Psoriatic Arthritis? - ARISE-PSA

Kerckhoff-Klinik0 个研究点目标入组 120 人开始时间: 2026年8月24日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 —(—)
性别
All

入选标准

  • •Confirmed diagnosis of psoriatic arthritis according to the CASPAR classification criteria
  • •Active disease (DAPSA >4)
  • •Current treatment with self-administered medication (e.g. oral or subcutaneous) or planned initiation or switch to such treatment based on clinical indication
  • •At least one and no more than five previous DMARD therapies
  • •Self-rated disease-related knowledge of moderately informed or worse
  • •Ability to complete study questionnaires independently
  • •Sufficient German language skills
  • •Written informed consent

排除标准

  • •Current or planned intravenous antirheumatic therapy
  • •Other inflammatory rheumatic systemic diseases likely to affect study outcomes
  • •Severe cognitive impairment or relevant psychiatric disorders
  • •Neurological disorders or contraindications to Augmented Reality applications (e.g. photosensitive epilepsy)
  • •Acute severe comorbidities
  • •Participation in another interventional clinical trial
  • •Unwillingness or inability to comply with the study protocol

研究组 & 干预措施

Group 1: Intervention group (Augmented Reality-assisted patient education): Following screening, written informed consent and baseline assessments, participants are randomized in a 1:1 ratio. Participants allocated to this study arm receive a single structured 20-minute patient education session on psoriatic arthritis using an Augmented Reality application. The education is delivered by trained medical staff according to a standardized educational protocol and covers disease characteristics, pathophysiology, structural changes, and the principles and goals of medical treatment. Routine medical care remains unchanged throughout the study. Follow-up assessments are performed 1 hour and 4, 12, and 24 weeks after the intervention.

干预措施: Group 1: Intervention group (Augmented Reality-assisted patient education): Following screening, written informed consent and baseline assessments, participants are randomized in a 1:1 ratio. Participants allocated to this study arm receive a single structured 20-minute patient education session on psoriatic arthritis using an Augmented Reality application. The education is delivered by trained medical staff according to a standardized educational protocol and covers disease characteristics, pathophysiology, structural changes, and the principles and goals of medical treatment. Routine medical care remains unchanged throughout the study. Follow-up assessments are performed 1 hour and 4, 12, and 24 weeks after the intervention.

研究者

相似试验